Skip to main content
. 2022 Sep 7;2022:8285084. doi: 10.1155/2022/8285084

Table 1.

Clinical and demographic characteristics of patients and individuals participating in the study.

Variable HD
n = 17
AKI(-)
n = 17
AKI(+)
n = 17
Gender,n(%)
Male 16 (94) 14 (82) 15 (88)
Female 1 (6) 3 (18) 2 (12)
Age (years, median (IQR)) 31 [23–63] 39 [24–57] 42 [22–39]
Occurrence zone,n(%)
Rural 16 (94) 15 (88)
Urban 1 (6) 2 (12)
Bite classification,n(%)
Mild 17 (100)
Severe 17 (100)
Anatomical site of the bite,n(%)
Upper limbs 5 (29) 4 (23)
Lower limbs 12 (71) 13 (77)
Previous snakebite,n(%)
Yes 3 (18)
No 14 (82) 17 (100)
Adverse reaction to antivenom,n(%)
Yes 2 (12) 3 (18)
No 15 (88) 14 (82)
Comorbidities,n(%)
Yes 1 (6) 4 (23)
No 16 (94) 13 (77)
Time to medical assistance (hours,n(%))
0 – 3 12 (71) 10 (59)
4 – 6 5 (29) 2 (12)
>6 5 (29)
Time to development of AKI (hours,n(%))
≤24 10 (59)
>24 7 (41)